ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | +28.6% | 14,200 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -46.2% | 14,200 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -77.2% | 14,200 | -71.9% | 0.00% | -100.0% |
| Q4 2021 | $57,000 | -36.7% | 50,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $90,000 | -45.5% | 50,500 | +1.0% | 0.00% | -42.9% |
| Q2 2021 | $165,000 | -1.8% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $168,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |